Q1 2018 Press Conference, and Analyst Call
Our Q1/2018 results will be published on May 15, 2018, at 7 a.m. CEST. Our press conference will take place at 9:30 AM CET, and the analyst call at 2 p.m. CEST
Type of Event
Conference Call
15 May 2018
From 07:00 to 15:00
We achieve targets for 2017 – dividend to increase
- Healthcare and Life Science drive sales growth (+2.0%)
- EBITDA pre (–1.7%) burdened by currency headwinds
- Organic sales growth in all regions
- Progress made in reducing net financial debt
- Dividend proposal € 1.25 (+€ 0.05)
We are staying the course
“2017 was a good year for our company. We performed well in a challenging environment and met all ourtargets for the year. We are staying the course and will continue to purposefully implement our innovation-driven growth strategies for Healthcare, Life Science and Performance Materials. In addition, we are resolutely working to quickly lower our acquisition-related debt-to-equity ratio.”
(Stefan Oschmann, CEO and Chairman of the Executive Board)
ADDITIONAL INFORMATION & DOWNLOADS
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, Reports a Solid Start to 2018
Merck KGaA, Darmstadt, Germany today reported a decline in sales in the first quarter of 2018 despite organic growth. This was due to negative foreign exchange effects.
2018/05/15